The Lancet Diabetes and Endocrinology

Aims & Scope

Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally.

The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	41.8
2024	44.00

SJR (SCImago Journal Rank)

Year	Value
2024	12.190

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	189

Journal Rank

Year	Value
2024	53

Journal Citation Indicator

Year	Value
2024	6796

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables

  Citation: 1792

  Authors: Emma, Petter, Annemari, Mats, Mozhgan, Annelie, Petter, Rashmi B, Dina Mansour, Peter, Ylva, Nael, Peter, Hindrik, Eero, Olle, Ola, Ulf, Ã…ke, Kaj, Tom, Tiinamaija, Anders H, Leif

• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

  Citation: 1262

  Authors: Søren L, Rasmus, Pardeep S, Kieran F, Naveed, David, Lars, Mark C, John J V

• Epidemiology and determinants of obesity in China

  Citation: 1161

  Authors: Xiong-Fei, Limin, An

• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

  Citation: 1119

  Authors: Naveed, Matthew M Y, Søren L, Kelley R H, Stefano, Nardev S, Carolyn S P, Renato D, John J V, Richard E, Julio, Hertzel C

• Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

  Citation: 1110

  Authors: Ian J, Robert, Jean-Pierre, Yuji, Shizuya, Iris, Jaap, Paolo, Raul D, Benoit, Ada, Frank B, Bruce, Alberto, Philip, Jean-Charles, Robert H

• Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

  Citation: 1043

  Authors: Hannele

• Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK

  Citation: 953

  Authors: Krishnan, Isabel, David A, Ian J, Liam

• Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people

  Citation: 940

  Authors: Anoop Dinesh, Claudia, Eleni, Spiros, Mar, Chris P, John, Liam, Adam, Harry

• The obesity transition: stages of the global epidemic

  Citation: 919

  Authors: Lindsay M, Stefanie, An, Craig J, Chelsea, Fumiaki, Dariush, Boyd, Majid

• Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases

  Citation: 874

  Authors: Rita Rastogi, Mark, Luigi

---